Literature DB >> 29127038

Lysine-containing cationic liposomes activate the NLRP3 inflammasome: Effect of a spacer between the head group and the hydrophobic moieties of the lipids.

Tianshu Li1, Jieyan He2, Gabor Horvath3, Tomasz Próchnicki3, Eicke Latz3, Shinji Takeoka4.   

Abstract

Cationic lipids containing lysine head groups and ditetradecyl, dihexadecyl or dioctadecyl glutamate hydrophobic moieties with/without propyl, pentyl or heptyl spacers were applied for the preparation of cationic liposomes using a simple bath type-sonicator. The size distribution, zeta potential, cellular internalization, and cytotoxicity of the liposomes were characterized, and the innate immune stimulation, e.g., the NLRP3 inflammasome activation of human macrophages and THP-1 cells, was evaluated by the detection of IL-1β release. Comparatively, L3C14 and L5C14 liposomes, made from the lipids bearing lysine head groups, ditetradecyl hydrophobic chains and propyl or pentyl spacers, respectively, were the most potent to activate the NLRP3 inflammasome. The possible mechanism includes endocytosis of the cationic liposomes and subsequent lysosome rupture without significant inducement of reactive oxygen species production. In summary, we first disclosed the structural effect of cationic liposomes on the NLRP3 inflammasome activation, which gives an insight into the application of nanoparticles for improved immune response.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cationic liposomes; Il-1β; Lysine; Lysosome rupture; NLRP3 inflammasome activation

Mesh:

Substances:

Year:  2017        PMID: 29127038     DOI: 10.1016/j.nano.2017.10.011

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  4 in total

1.  Intracellular Distribution of Lipids and Encapsulated Model Drugs from Cationic Liposomes with Different Uptake Pathways.

Authors:  Masato Takikawa; Mizuki Fujisawa; Kazuma Yoshino; Shinji Takeoka
Journal:  Int J Nanomedicine       Date:  2020-10-29

Review 2.  Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome.

Authors:  Malvina Pizzuto; Pablo Pelegrin; Jean-Marie Ruysschaert
Journal:  Prog Lipid Res       Date:  2022-07-25       Impact factor: 14.673

3.  NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells.

Authors:  Tianshu Li; Matthias Zehner; Jieyan He; Tomasz Próchnicki; Gabor Horvath; Eicke Latz; Sven Burgdorf; Shinji Takeoka
Journal:  Int J Nanomedicine       Date:  2019-05-13

Review 4.  Inflammasomes as Targets for Adjuvants.

Authors:  Konstantin Ivanov; Ekaterina Garanina; Albert Rizvanov; Svetlana Khaiboullina
Journal:  Pathogens       Date:  2020-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.